calrlong36
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 20, 2018 (NCT03566446)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03566446 | Phase 1 | Jun 20, 2018 | Center for Cancer Immune Therapy, Denmark, University of Copenhagen |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Center for Cancer Immune Therapy, Denmark | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2018 |
2 organizations
Page 1 / 1